ArticleScientific reports2025
Accelerating infectious wound healing through bacterial cellulose/ag composite film enriched with GM-CSF.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biocompatible Photocrosslinked Chitosan- and Gelatin-Based Hydrogels for Wound Healing Applications.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Infectious wounds have increasingly become a significant clinical challenge due to their high incidence and suboptimal treatment outcomes. An ideal wound dressing would be a smart, in situ-formed material with exceptional antibacterial properties and the ability to eliminate biofilms, thereby facilitating effective wound closure. Bacterial cellulose (BC) is an attractive candidate for wound healing applications due to its unique characteristics, including high water retention, flexibility, biocompatibility, and substantial adsorption capacity. However, its limited antibacterial activity constrains its use in skin wound healing. In this work, we employed BC as a matrix material, silver nanoparticles (Ag) as antibacterial agents, and granulocyte-macrophage colony-stimulating factor (GM-CSF) as a cell growth-promoting factor to enhance the healing of infected chronic wounds. The resulting BC/Ag/GM-CSF composite demonstrated excellent blood compatibility, cell compatibility, and antibacterial efficacy. Additionally, the BC/Ag/GM-CSF composite film shows promising potential as a wound dressing for both acute and chronic infectious wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.